Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Endocrine Oncology is Scopus-indexed (Q4, CiteScore 1), WoS ESCI, DOAJ. Published by BioScientifica Ltd..
Checked against the index lists dated .
ISSN 2634-4793Verify ISSN ↗
Publisher: BioScientifica Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 343 / 428 | 19th | Q4 |
| Endocrinology, Diabetes and Metabolism | 204 / 250 | 18th | Q4 |
| Cancer Research | 204 / 233 | 12th | Q4 |
| Endocrinology | 121 / 132 | 8th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2024–present, best quartile Q4, CiteScore 1.
Endocrine Oncology is Q4 in Oncology (rank 343 of 428), Q4 in Endocrinology, Diabetes and Metabolism (rank 204 of 250) and Q4 in Cancer Research (rank 204 of 233), by CiteScore 2025. It is ranked in 4 subject areas in all.
Endocrine Oncology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1, which places it in quartile Q4 at the 19th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.397, quartile Q3, with an H-index of 4.
Endocrine Oncology is published by BioScientifica Ltd. Its ISSN is 2634-4793.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Endocrine Oncology has an h-index of 12 and a 2-year mean of 0.9 citations per paper (OpenAlex). Its Scopus CiteScore is 1, quartile Q4. On 2-year citations it ranks #300 of 424 Scopus journals in Oncology.
Endocrine Oncology published 55 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 80 research articles (2024–2026), authors are most often from United States (23.1%), United Kingdom (18.6%) and Brazil (10.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.